Jan Basile
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
-
- Blood Pressure and Hypertension Studies
- Heart Failure Treatment and Management
- Renin-Angiotensin System Studies
Papers in
-
- Blood Pressure and Hypertension Studies 137
- Heart Failure Treatment and Management 9
- Renin-Angiotensin System Studies 7
-
- Diabetes Treatment and Management 18
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Co-authors
- Barry L. Carter (5 shared papers)Michael J. Bloch (71 shared papers)Alan H. Gradman (5 shared papers)George L. Bakris (4 shared papers)Brent M. Egan (15 shared papers)William C. Cushman (16 shared papers)Karen L. Margolis (4 shared papers)Michael Rakotz (1 shared paper)
- Journals
- Journal of Clinical Hypertension (95 papers)Hypertension (6 papers)The Lancet (5 papers)Journal of the American Society of Hypertension (5 papers)The American Journal of the Medical Sciences (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Jan Basile
200 papers receiving 9k citations
Jan Basile's Hit Papers
Peers
Comparison fields: 5 of 124
- Endocrinology, Diabetes and Metabolism 3.4k
- Cardiology and Cardiovascular Medicine 3.5k
- Nephrology 1.2k
- Family Practice 89
- Physiology 407
Countries citing papers authored by Jan Basile
This map shows the geographic impact of Jan Basile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Basile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Basile more than expected).
Fields of papers citing papers by Jan Basile
This network shows the impact of papers produced by Jan Basile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Basile. The network helps show where Jan Basile may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Basile, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 217 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2345 |
| 2 | Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial Hit paper breakdown → | 2010 | 1126 |
| 3 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 498 |
| 4 | Effects of Intensive BP Control in CKD Hit paper breakdown → | 2017 | 378 |
| 5 | Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial Hit paper breakdown → | 2021 | 302 |
| 6 | Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association Hit paper breakdown → | 2020 | 279 |
| 7 | Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial Hit paper breakdown → | 2020 | 229 |
| 8 | 2010 | 195 | |
| 9 | Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics Hit paper breakdown → | 2023 | 174 |
| 10 | 2010 | 167 | |
| 11 | 2017 | 148 | |
| 12 | 2014 | 145 | |
| 13 | 2006 | 135 | |
| 14 | Endovascular Ultrasound Renal Denervation to Treat Hypertension Hit paper breakdown → | 2023 | 124 |
| 15 | 2007 | 110 | |
| 16 | 2010 | 110 | |
| 17 | 2009 | 108 | |
| 18 | 2016 | 101 | |
| 19 | 2020 | 99 | |
| 20 | 2019 | 96 |
About Jan Basile
Jan Basile is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Nephrology, Family Practice and Pulmonary and Respiratory Medicine, having authored 217 papers that have together received 9.6k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (137 papers), Diabetes Treatment and Management (18 papers), Chronic Kidney Disease and Diabetes (13 papers), Heart Failure Treatment and Management (9 papers), Renal and Vascular Pathologies (7 papers), Renin-Angiotensin System Studies (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Lipoproteins and Cardiovascular Health (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.4k citations), Cardiology and Cardiovascular Medicine (3.5k citations), Nephrology (1.2k citations), Family Practice (89 citations) and Physiology (407 citations). Jan Basile has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Barry L. Carter, Michael J. Bloch, Alan H. Gradman, George L. Bakris, Brent M. Egan, William C. Cushman, Karen L. Margolis, Michael Rakotz, Nancy T. Artinian and Daichi Shimbo. Their work appears in journals such as Journal of Clinical Hypertension, Hypertension, The Lancet, Journal of the American Society of Hypertension and The American Journal of the Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.